An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
1 Microbiology and Infectious Diseases Department, Institut de Recherche Biomédicale des Armées, Place Générale Valérie André, Brétigny-sur-Orge 91220, France; Respiratory Department, Hôpital d'Instruction des Armées Percy, Clamart 92140, France. Electronic address: frdriviere@orange.fr.
2 Molecular Immunology and Virology Unit, Institut National de la Recherche Agronomique, Domaine de Vilvert, Jouy-en-Josas Cedex 78352, France.
3 Microbiology and Infectious Diseases Department, Institut de Recherche Biomédicale des Armées, Place Générale Valérie André, Brétigny-sur-Orge 91220, France.
4 Lyssavirus Epidemiology and Neuropathology Unit, Institut Pasteur, Paris 75015, France.
1 Microbiology and Infectious Diseases Department, Institut de Recherche Biomédicale des Armées, Place Générale Valérie André, Brétigny-sur-Orge 91220, France; Respiratory Department, Hôpital d'Instruction des Armées Percy, Clamart 92140, France. Electronic address: frdriviere@orange.fr.
2 Molecular Immunology and Virology Unit, Institut National de la Recherche Agronomique, Domaine de Vilvert, Jouy-en-Josas Cedex 78352, France.
3 Microbiology and Infectious Diseases Department, Institut de Recherche Biomédicale des Armées, Place Générale Valérie André, Brétigny-sur-Orge 91220, France.
4 Lyssavirus Epidemiology and Neuropathology Unit, Institut Pasteur, Paris 75015, France.
Declaration of Competing Interest None. The images have not been previously published.
Figures
Fig. 1
Comparative analysis with 2MP of…
Fig. 1
Comparative analysis with 2MP of lung injury after infection with SARS-Cov2 or Influenzavirus …
Fig. 1
Comparative analysis with 2MP of lung injury after infection with SARS-Cov2 or Influenzavirus. The images above show two 2-photon micrographs (2PM) of normal hamster (A) and mouse (B) lung parenchyma. Alveolar/bronchial epithelium tissue is shown in yellow (A) or green (B) and connective tissue (in both micrographs) is blue. Two 2PM micrographs of pulmonary parenchyma showing the distribution of SARS-Cov-2 (C) or the A/PR8 influenza (D) virus 72 h after infection. In (C) the hamster tissue was stained with the SARS-Cov-2 Spike antibody and a secondary antibody coupled with AF568, an orange-red dye. In (D) the mouse tissue was stained with an endogen fluorescence NS1 coupled with a red fluorescent marker (RFP). The images show that SARS-CoV-2 was localized exclusively on the alveolar epithelium whereas the influenza virus was predominantly localized the on bronchial and alveolar epithelia. Two 2PM micrographs of pulmonary bronchial epithelia 72 h after infection with either SARS-Cov-2 (E) or A/PR8 influenza (F) virus. In (E) the hamster tissue was stained with the SARS-Cov-2 Spike antibody and a secondary antibody coupled with AF568, an orange-red dye. In (F) the mouse tissue was stained with an endogen fluorescence NS1 coupled with a red fluorescent marker (RFP) to visualise the influenza virus. The bronchial epithelium (E) had a normal structure 72 h following infection with Sars-Cov-2 in contrast to the epithelium (F) which showed signs of severe injury following infection with Influenzavirus.
Fig. 2
Comparison of three 2PM images…
Fig. 2
Comparison of three 2PM images showing localized macrophage recruitment in pulmonary epithelial tissue…
Fig. 2
Comparison of three 2PM images showing localized macrophage recruitment in pulmonary epithelial tissue 72 h after infection with either SARS-Cov-2 virus (A) and (B), or A/PR8 influenza (C). In all slides an F4/80 antibody coupled with a blue BV421 fluorescent marker was used to stain the macrophages. In slides (A) and (B) the SARS-Cov-2 Spike antibody and a secondary antibody coupled with AF568 (an orange-red dye) were used to stain the SARS-Cov-2 virus and in slide (C) an endogenous, fluorescent NS1 coupled with a red fluorescent marker (RFP) were used to visualise the influenza virus. Macrophage recruitment in SARS-Cov-2 infected lungs was heterogenous, with diseased (A) and healthy areas (B) in the same organ. This variation in macrophage distribution differed from the general, diffuse macrophage recruitment from the perivascular area observed in lung tissue after infection with influenza (C).
Salata C., Calistri A., Parolin C., Palù G. Coronaviruses: a paradigm of new emerging zoonotic diseases. Pathog Dis. 2019;77:ftaa006. 1 déc.
-
PMC
-
PubMed
Piroth L., Cottenet J., Mariet A.S., Bonniaud P., Blot M., Tubert-Bitter P., et al. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. Lancet Respir Med. 2021;9:251–259. mars.
-
PMC
-
PubMed
Erich P., Mario K., Theresa M., Sara O., Hasan K., Sebastian B., et al. COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria. Infection. 2021;49(5):907–916. doi: 10.1007/s15010-021-01610-z.
-
DOI
-
PMC
-
PubMed
Hariri L.P., North C.M., Shih A.R., Israel R.A., Maley J.H., Villalba J.A., et al. Lung histopathology in coronavirus disease 2019 as compared with severe acute respiratory sydrome and H1N1 influenza. Chest. 2021;159:73–84. janv.
-
PMC
-
PubMed